CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in FTRE — Fortrea Holdings Inc.

CIK 884546 SAN FRANCISCO, CA

Position in FTRE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$30,216,279

-$25,311,971 QoQ

Shares Held

3,207,673

-0.4% QoQ

Ownership

3.39%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 99.99710070197305.ToString("F0")% Shared 0.ToString("F0")% None 0.0028992980269497547.ToString("F0")%

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,181,979,796 across 287 Biotechnology names. FTRE ranks #45 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,920,871	$857,745,736
2	REGN	Regeneron Pharmaceuticals, Inc.	804,508	$621,595,061
3	MRNA	Moderna, Inc.	4,734,356	$240,505,284
4	ALNY	Alnylam Pharmaceuticals, Inc.	673,356	$222,793,299
5	INSM	INSMED Inc	1,069,390	$174,866,652
6	RVMD	Revolution Medicines, Inc.	1,735,476	$168,775,041
7	INCY	Incyte Corp	1,729,102	$162,743,080
8	BBIO	BridgeBio Pharma, Inc.	1,976,094	$146,744,740

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$30,216,279	3,207,673	-0.4%	Shares	Sole	2026-05-15
2025-12-31	$55,528,250	3,219,029	+21.3%	Shares	Sole	2026-02-13
2025-09-30	$22,339,421	2,653,138	+48.2%	Shares	Sole	2025-11-10
2025-06-30	$8,840,940	1,789,664	+88.0%	Shares	Sole	2025-08-12
2025-03-31	$7,187,758	952,021	+55.3%	Shares	Sole	2025-09-15
2024-12-31	$11,430,529	612,897	+3.8%	Shares	Sole	2025-02-06
2024-09-30	$11,808,560	590,428	+5.2%	Shares	Sole	2024-11-12
2024-06-30	$13,097,077	561,143	-1.0%	Shares	Sole	2024-08-12
2024-03-31	$22,759,741	567,009	-8.2%	Shares	Sole	2024-05-09
2023-12-31	$21,549,319	617,459	+6.4%	Shares	Sole	2024-02-06
2023-09-30	$16,595,094	580,451	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.